ICOS to Participate in Upcoming Investment Conference
January 23 2006 - 8:00PM
Business Wire
ICOS Corporation (Nasdaq:ICOS) announced today that it will
participate in the Merrill Lynch Global Pharmaceutical,
Biotechnology, and Medical Device Conference on Thursday, February
9, 2006. The presentation, which may include a discussion of
financial guidance and future plans, will be webcast. -0- *T
Merrill Lynch Conference Presentation Date: February 9, 2006 Time:
11:00 a.m. EST Speaker: Paul N. Clark, Chairman, President and CEO
*T A webcast of this ICOS presentation will be available in
real-time and a replay will be available through February 16, 2006.
The webcast can be accessed through the ICOS Web site,
www.icos.com, Investor -- Events section. Additional information on
ICOS, including past press releases, is also available at
www.icos.com. About ICOS Corporation: ICOS Corporation, a
biotechnology company headquartered in Bothell, Washington, is
dedicated to bringing innovative therapeutics to patients. Through
Lilly ICOS LLC, ICOS is marketing its first product, Cialis(R)
(tadalafil), for the treatment of erectile dysfunction. ICOS is
working to develop treatments for serious unmet medical conditions
such as pulmonary arterial hypertension, benign prostatic
hyperplasia, hypertension, cancer and inflammatory diseases. This
press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements involve risks and uncertainties
that could cause ICOS' results and the timing of certain events to
differ materially from those discussed in the forward-looking
statements, including risks associated with product
commercialization, manufacturing activities, clinical development,
regulatory approvals, intellectual property claims and litigation
and other risks detailed in ICOS' latest Quarterly Report on Form
10-Q and its other SEC filings.
Icos (NASDAQ:ICOS)
Historical Stock Chart
From Apr 2024 to May 2024
Icos (NASDAQ:ICOS)
Historical Stock Chart
From May 2023 to May 2024